Myriad Genetics, Inc. (MYGN)

Myriad Genetics Market Cap

Myriad Genetics has a market cap or net worth of $478.76 million as of March 10, 2026. Its market cap has decreased by -62.91% in one year.

• Market Cap: 478.76M
• Enterprise Value: 538.96M
• 1-Year Change: -62.91%
• Ranking: #3115
• Category: Small-Cap
• Stock Price: $5.12

Market Cap Chart

Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $478.76M, an increase of 368.00%. That is a compound annual growth rate of 5.82%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	449.80M	-21.54%
Dec 31, 2025	573.30M	-54.07%
Dec 31, 2024	1.25B	-20.67%
Dec 29, 2023	1.57B	33.81%
Dec 30, 2022	1.18B	-46.65%
Dec 31, 2021	2.20B	48.19%
Dec 31, 2020	1.49B	-26.57%
Dec 31, 2019	2.03B	-6.80%
Dec 31, 2018	2.17B	-8.61%
Dec 29, 2017	2.38B	108.51%
Dec 30, 2016	1.14B	-62.13%
Dec 31, 2015	3.01B	21.14%
Dec 31, 2014	2.49B	58.51%
Dec 31, 2013	1.57B	-29.30%
Dec 31, 2012	2.22B	25.03%
Dec 30, 2011	1.77B	-15.91%
Dec 31, 2010	2.11B	-15.93%
Dec 31, 2009	2.51B	-18.54%
Dec 31, 2008	3.08B	50.95%
Dec 31, 2007	2.04B	64.00%
Dec 29, 2006	1.24B	93.29%
Dec 30, 2005	643.90M	-6.71%
Dec 31, 2004	690.20M	98.11%
Dec 31, 2003	348.40M	-0.17%
Dec 31, 2002	349.00M	-71.84%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
NeoGenomics	1.16B
CareDx	916.26M
OPKO Health	895.70M
Personalis	820.31M
Castle Biosciences	806.31M
Fulgent Genetics	456.90M
Prenetics Global	299.55M
Burning Rock Biotech	239.56M